4.3 Article

Diagnoses and treatments for participants with interstitial lung abnormalities detected in the Yorkshire Lung Screening Trial

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Respiratory System

Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease

Richard J. Hewitt et al.

Summary: This retrospective study explores the impact of incidentally detected interstitial lung abnormalities (ILA) on the diagnosis and treatment of interstitial lung disease (ILD). The study found that the rate of de novo ILD diagnosis was 1.5% in a targeted lung cancer screening program. The extent of abnormality on CT and severity of lung function impairment were the most important factors in differentiating ILA from ILD.

THORAX (2022)

Article Oncology

Incidental findings in low dose CT lung cancer screening of high-risk smokers: Results from the Manchester lung Health Check pilot

P. Bradley et al.

Summary: This study reports the prevalence of incidental findings in a lung cancer screening program. It found a significant number of extra-pulmonary malignancies, leading to further clinical management and interventions.

LUNG CANCER (2022)

Article Critical Care Medicine

Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

Hiroto Hatabu et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Critical Care Medicine

Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial

Stacey-Ann Whittaker Brown et al.

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Letter Respiratory System

Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography

Justin M. Oldham et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)

Article Medicine, General & Internal

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Medicine, General & Internal

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

Interstitial Lung Abnormalities in a CT Lung Cancer Screening Population: Prevalence and Progression Rate

Gong Yong Jin et al.

RADIOLOGY (2013)

Article Respiratory System

Interstitial lung diseases in a lung cancer screening trial

N. Sverzellati et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

Article Medicine, General & Internal

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Denise R. Aberle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Lung Morphology in the Elderly: Comparative CT Study of Subjects over 75 Years Old versus Those under 55 Years Old

Susan J. Copley et al.

RADIOLOGY (2009)

Article Oncology

The LLP risk model: an individual risk prediction model for lung cancer

A. Cassidy et al.

BRITISH JOURNAL OF CANCER (2008)

Article Cardiac & Cardiovascular Systems

The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK

Ivan Le Jeune et al.

RESPIRATORY MEDICINE (2007)